CN104225228A - Traditional Chinese medicine preparation for regulating blood sugar - Google Patents

Traditional Chinese medicine preparation for regulating blood sugar Download PDF

Info

Publication number
CN104225228A
CN104225228A CN201410463542.2A CN201410463542A CN104225228A CN 104225228 A CN104225228 A CN 104225228A CN 201410463542 A CN201410463542 A CN 201410463542A CN 104225228 A CN104225228 A CN 104225228A
Authority
CN
China
Prior art keywords
chinese medicine
medicine preparation
parts
blood glucose
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410463542.2A
Other languages
Chinese (zh)
Other versions
CN104225228B (en
Inventor
贾孝荣
王新本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANZHOU GUCHI BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
LANZHOU GUCHI BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANZHOU GUCHI BIOLOGICAL TECHNOLOGY Co Ltd filed Critical LANZHOU GUCHI BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN201410463542.2A priority Critical patent/CN104225228B/en
Publication of CN104225228A publication Critical patent/CN104225228A/en
Application granted granted Critical
Publication of CN104225228B publication Critical patent/CN104225228B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a traditional Chinese medicine preparation for regulating blood sugar and belongs to the field of traditional Chinese medicines. According to the medicine disclosed by the invention, lycium barbarum, rhizoma polygonati, folium mori and broadleaf holly leaf serving as raw materials are compatible with one another, so that a synergistic effect is achieved among effects of the medicines, the medicines have the effects of nourishing yin in lung, spleen and kidney, and due to treatment of upper, middle and lower Jiao, the problem of blood sugar imbalance is fundamentally solved. The clinical detection data proves that the medicine disclosed by the invention has a clear effect of regulating blood sugar. Moreover, the traditional Chinese medicine preparation disclosed by the invention is used for both prevention and control, can be used for preventing the diabetes and can condition the ill glucose fluctuation state.

Description

A kind of for regulating the Chinese medicine preparation of blood glucose
Technical field
The present invention relates to a kind of for regulating the Chinese medicine preparation of blood glucose, belonging to Chinese medicine health-care field.
Background technology
Sugar is one of requisite nutrition of our health.People take in corn, vegetables and fruits etc., are converted into monosaccharide (as glucose etc.) and enter blood, be transported to systemic cell, as the source of energy through digestive system.If not consumed for the moment, be then converted into glycogen storage in liver and muscle, liver can store up sugared 70 ~ 120 grams, account for liver heavy 6 ~ 10%.The glycogen that cell can store is limited, if the sugared part taken in is too much, namely unnecessary sugar change fat into.
Sugared part in blood is called blood glucose, is all glucose (Glu write a Chinese character in simplified form in English) in most cases.Energy in body needed for each histiocyte activity is most of from glucose, so blood glucose must keep certain level could maintain the needs of each Organ and tissue in body.Normal person is 3.9-6.1mmol/L at fasting plasma glucose concentration.Fasting plasma glucose concentration is called hyperglycemia more than 7.0mmol/L.Hyperglycemia can cause microangiopathies, makes the microcirculation of patient have exception in various degree.Along with the course of disease prolongation and treatment can impel increasing the weight of and developing of microangiopathies not in time, make patient's blinding, disable.Microangiopathies is mainly manifested in retina, kidney, cardiac muscle, nervous tissue and toes, and patient is experienced ailing torment.Hyperglycemia also can cause macroangiopathy.The atherosclerosiss such as such as aorta, coronary artery, basilar artary, renal artery and peripheral arterial.Wherein, the atherosclerosis state of an illness is heavier, case fatality rate is high.About 70%-80% diabetics dies from diabetic macroangiopathy.Blood sugar concentration is called hypoglycemia lower than 3.61mmol/L.Hypoglycemia brings great harm to patient, and the lighter causes hypomnesis, bradykinesia, dementia, stupor, until threat to life; Some patients brings out cerebrovas-cularaccident, arrhythmia and myocardial infarction.Therefore, regulating blood glucose balance to be the important component part that vital movement regulates, is the essential condition of holder homeostasis.
At present, for hyperglycemia mainly through insulin injection to maintain blood glucose balance, and for hypoglycemia, mainly mainly maintain blood glucose balance by intravenous injection glucose or glucagon by reconciling hypoglycemic medicament.This regulative mode not only costly, and fundamentally can not solve the unbalanced problem of blood glucose, the more important thing is that life-time service has certain side effect to human body.
Summary of the invention
The object of this invention is to provide a kind of for regulating the Chinese medicine preparation of blood glucose, fundamentally to solve the unbalanced problem of blood glucose.
Chinese medicine preparation of the present invention, with Fructus Lycii, Rhizoma Polygonati, Folium Mori, Folium Ilicis is that raw material carries out compatibility, effect of each medicine is produced collaborative, plays effect of the moon growing cloudy, the foster lung spleen kidney of lung spleen kidney altogether, by upper, middle and lower three, Jiao rules together, and fundamentally solves the unbalanced problem of blood glucose.
Fructus Lycii, sweet in the mouth, property is put down; Return liver, kidney channel; Nourishing the liver and kidney, replenishing vital essence to improve eyesight.For asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, and blurred vision is failed to understand.Modern pharmacological research then proves, containing 14 seed amino acids in Fructus Lycii, and containing special dietary compositions such as betanin, beautiful another name for Sichuan Province flavin, physalins, makes it have outstanding health-care effect.
Rhizoma Polygonati, sweet in the mouth, property is put down; Return spleen, lung, kidney channel; Boosting qi and nourishing yin, spleen invigorating, lung moistening, kidney tonifying; For weakness of the spleen and stomach, fatigue and asthenia, xerostomia lack of appetite, deficiency of the lung cough caused by dryness, asthenia of essence and blood, interior-heat is quenched one's thirst.Modern study shows, Rhizoma Polygonati has antibacterial action and reduces the effect of body blood pressure.
Folium Mori, bitter in the mouth, sweet, cold in nature; Return lung, Liver Channel; Dispelling wind and heat pathogens, liver heat removing and eyesight improving, clearing away lung-heat and moistening for dryness, YIN nourishing and the production of body fluid promoting, suppressing liver-YANG.Modern study shows, Folium Mori have blood sugar lowering blood fat, cholesterol reducing, antithrombus formation and atherosclerosis DENG effect.
Folium Ilicis, sweet; Bitter; Cold.Enter liver, lung, stomach warp; Wind and heat dispersing; Improving eyesight is promoted the production of body fluid.Modern pharmacological research proves, the trace element such as the several amino acids not only containing needed by human in Folium Ilicis, vitamin and zinc, manganese, rubidium, also there is blood fat reducing, increase coronary artery blood flow, increase the effect such as blood supply of cardiac muscle, atherosclerosis, all have good preventive and therapeutic effect to symptoms such as the dizziness of Patients with Cardiovascular/Cerebrovascular Diseases, headache, uncomfortable in chest, weak, insomnias.
The present invention takes on monarch drug with Fructus Lycii, the duty of the moon of part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels Liver and kidney in department's nourishing; Rhizoma Polygonati takes on ministerial drug, and the duty of the moon of lung spleen kidney is nourished by department; Folium Mori take on adjuvant drug, the duty that department's evacuation part of the body cavity above the diaphragm housing the heart and lungs wind heat, the clear sharp part of the body cavity above the diaphragm housing the heart and lungs are scorching; Folium Ilicis, as making medicine, takes charge of heat clearing away and the duty of promoting the production of body fluid.Full side plays effect of the moon growing cloudy, the foster lung spleen kidney of lung spleen kidney altogether.
Confirm through our years of researches, as quench one's thirst (diabetes), " above disappear slightly to disappear, in disappear just disappear, under disappear and disappear especially." the present invention not will not have clearly nurse one's health blood glucose effect Folium Ilicis as the monarch and his subjects' adjuvant drug; but act on the principle of " cure the disease and must ask it "; ruled together (the main part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels of Fructus Lycii; burnt in Rhizoma Polygonati master; Folium Mori Your Majesty is burnt) by upper, middle and lower three Jiao, imply upper, middle and lower three and disappear and control, do not ask quick-acting; and from long-range, fundamentally to solve the problem of quenching one's thirst.
Chinese medicine preparation of the present invention carries out proportioning by following weight portion: Fructus Lycii 20-35 part, Rhizoma Polygonati 10-25 part, Folium Mori 5-15 part, Folium Ilicis 1-8 part.
Optimum ratio: Fructus Lycii 20-28 part, Rhizoma Polygonati 15-20 part, Folium Mori 10-12 part, Folium Ilicis 4-7 part.
Optimum proportioning: Fructus Lycii 24 parts, Rhizoma Polygonati 18 parts, 12 parts, Folium Mori, Folium Ilicis 6 parts.
Chinese medicine preparation of the present invention can be prepared into various oral preparations by the common process of pharmacy of Chinese materia medica and adjuvant.As capsule, tablet, granule, powder, pill (comprising the watered pill, honeyed pill, dragee, soft gelatin capsule, enteric coated pill or drop pill) or oral liquid.
Here is the clinical test results that Chinese medicine preparation of the present invention regulates blood glucose.
1, clinical observation object: select hypoglycemia and each 10 examples of hyperglycemic patients, man, female half and half, be adult.
2, Therapeutic Method: take granules medicine of the present invention (Qi Phellinus igniarius (L. ex Fr.) Quel. fourth tea): every bag of 5g.Using method: 3 times on the one, once take 1 bag.Serveing on 45 days is a course for the treatment of, observes for 3 courses for the treatment of.As women does not then stop using menstrual period.Blood glucose value is measured by luminous reflectance blood glucose meter.
3, measurement result: see the following form 1:
As can be seen from table 1 detection data we, medicine of the present invention has the effect of clear and definite adjustment blood glucose.Experiment also shows, Chinese medicine preparation control of the present invention is laid equal stress on, and both may be used for preventing diabetes, can also nurse one's health sick blood glucose fluctuation state.
Detailed description of the invention
Below by specific embodiment, the proportioning raw materials of medicine of the present invention, preparation and usage side are described further.
The preparation of embodiment 1, granules medicine
Composition of raw materials: Fructus Lycii 24 parts, Rhizoma Polygonati 18 parts, 12 parts, Folium Mori, Folium Ilicis 6 parts;
Preparation technology: prepare the common process of granule by pharmaceutics and adjuvant is prepared from.Specification: 5g/ bag, 20 bags/box;
Usage and dosage: 3 times on the one, once take 1 bag.Serveing on 45 days is a course for the treatment of.
The preparation of embodiment 2, capsule medicine
Composition of raw materials: Fructus Lycii 20 parts, Rhizoma Polygonati 15 parts, 10 parts, Folium Mori, Folium Ilicis 4 parts;
Preparation technology: prepare the common process of capsule by pharmaceutics and adjuvant is prepared from.Every 0.25g;
Using method: 3 times on the one, once take 3.Serveing on 45 days is a course for the treatment of.
The preparation of embodiment 3, tablet medicine
Composition of raw materials: Fructus Lycii 28 parts, Rhizoma Polygonati 20 parts, 12 parts, Folium Mori, Folium Ilicis 7 parts;
Preparation technology: prepare the common process of tablet by pharmaceutics and adjuvant is prepared from.Every sheet 1.0g;
Using method: 3 times on the one, once take 2.Serveing on 45 days is a course for the treatment of.
The preparation of embodiment 4, pill medicine
Composition of raw materials: Fructus Lycii 20 parts, Rhizoma Polygonati 10 parts, 5 parts, Folium Mori, Folium Ilicis 1 part;
Preparation technology: prepare the common process of pill by pharmaceutics and adjuvant is prepared from.Every 0.05g;
Using method: using method: 3 times on the one, once take 36.Serveing on 45 days is a course for the treatment of.
The preparation of embodiment 5, oral liquid
Composition of raw materials: Fructus Lycii 35 parts, Rhizoma Polygonati 25 parts, 15 parts, Folium Mori, Folium Ilicis 8 parts;
Preparation technology: prepare the common process of oral liquid by pharmaceutics and adjuvant is prepared from.Every bottle of 10ml;
Using method: 3 times on the one, once take 20ml.Serveing on 45 days is a course for the treatment of.
In the various embodiments described above, each proportioning raw materials is all with parts by weight.

Claims (5)

1. for regulating a Chinese medicine preparation for blood glucose, being with Fructus Lycii, Rhizoma Polygonati, Folium Mori, Folium Ilicis for raw material, being prepared into various oral preparations by the common process of pharmacy of Chinese materia medica and adjuvant.
2. as claimed in claim 1 for regulating the Chinese medicine preparation of blood glucose, it is characterized in that: described each raw material carries out proportioning by following weight portion: Fructus Lycii 20-35 part, Rhizoma Polygonati 10-25 part, Folium Mori 5-15 part, Folium Ilicis 1-8 part.
3. as claimed in claim 1 for regulating the Chinese medicine preparation of blood glucose, it is characterized in that: described each raw material carries out proportioning by following weight portion: Fructus Lycii 20-28 part, Rhizoma Polygonati 15-20 part, Folium Mori 10-12 part, Folium Ilicis 4-7 part.
4. as claimed in claim 1 for regulating the Chinese medicine preparation of blood glucose, it is characterized in that: described each raw material carries out proportioning by following weight portion: Fructus Lycii 24 parts, Rhizoma Polygonati 18 parts, 12 parts, Folium Mori, Folium Ilicis 6 parts.
5. as claimed in claim 1 for regulating the Chinese medicine preparation of blood glucose, it is characterized in that: described each raw material carries out proportioning by following weight portion: described oral preparations is capsule, tablet, granule, medicinal tea, pill or oral liquid.
CN201410463542.2A 2014-09-12 2014-09-12 A kind of Chinese medicine preparation for being used to adjust blood glucose Active CN104225228B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410463542.2A CN104225228B (en) 2014-09-12 2014-09-12 A kind of Chinese medicine preparation for being used to adjust blood glucose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410463542.2A CN104225228B (en) 2014-09-12 2014-09-12 A kind of Chinese medicine preparation for being used to adjust blood glucose

Publications (2)

Publication Number Publication Date
CN104225228A true CN104225228A (en) 2014-12-24
CN104225228B CN104225228B (en) 2018-05-25

Family

ID=52214704

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410463542.2A Active CN104225228B (en) 2014-09-12 2014-09-12 A kind of Chinese medicine preparation for being used to adjust blood glucose

Country Status (1)

Country Link
CN (1) CN104225228B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109418483A (en) * 2017-09-05 2019-03-05 许国华 Black fruit fructus lycii tea tree jasmine tea
CN110839805A (en) * 2019-11-22 2020-02-28 坤承(北京)健康管理有限公司 Plant solid beverage

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
侯昕等: "生药材调节血糖有效成分的研究", 《辽宁实用糖尿病杂志》 *
冯敏等: "辅助降糖食品的研究现状", 《中国食物与营养》 *
石悦: "《怎么吃血糖才会降》", 30 April 2011, 吉林科学技术出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109418483A (en) * 2017-09-05 2019-03-05 许国华 Black fruit fructus lycii tea tree jasmine tea
CN110839805A (en) * 2019-11-22 2020-02-28 坤承(北京)健康管理有限公司 Plant solid beverage

Also Published As

Publication number Publication date
CN104225228B (en) 2018-05-25

Similar Documents

Publication Publication Date Title
CN101822749B (en) Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof
CN102526479B (en) Health-care medicine formula with functions of enhancing immunity and lowering blood sugar
CN102526478B (en) Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar
CN105232907A (en) Beverage capable of invigorating kidney and strengthening Yang and making method thereof
CN102205095A (en) Medicinal composition with auxiliary blood sugar reducing effect
CN104126707A (en) Atherosclerosis-conditioning tea
CN103461585B (en) Qi tonifying and health preserving herbal tea
CN102578668B (en) Beverage for assisting in reducing blood sugar
CN109528904A (en) A kind of kidney-tonifying health-care, boosting qi and nourishing yin, pharmaceutical composition of high-content ginsenoside and preparation method thereof
CN1558768A (en) A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof
CN105395706A (en) Health care product for diabetes
CN102258628B (en) Chinese medicinal composition with lead removal promoting effect
CN104225228A (en) Traditional Chinese medicine preparation for regulating blood sugar
CN104208285B (en) A kind of Chinese medicine preparation for being used for female health and delaying failure of memory
CN105596735A (en) Medicine composition for treating diabetes mellitus
CN103238713B (en) Food healthy tea granule capable of tonifying and nourishing heart
CN108403818A (en) A kind of composition of auxiliary hyperglycemic and application thereof
CN103622027A (en) Health-care food composition for reducing blood glucose
CN105343506A (en) Method for preparing composition for treating type-2 diabetes
CN106729304B (en) A kind of Chinese medicine for mitigating fasting or side reaction of dieting and preparation method thereof
CN100394930C (en) Application of cassia seed in preparation of lead-remove promoting drug or health-caring product
CN104189360A (en) Chinese herb preparation used for breast strengthen and enhancement of women
CN102847006A (en) Chinese traditional medicine prescription for treating diabetes mellitus
CN106728678A (en) The herbal mixture and preparation method of hypoglycemic
CN106138680B (en) Traditional Chinese medicine composition with antioxidant function

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant